Ependymoma surgery: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
| Line 24: | Line 24: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 22:19, 26 November 2017
|
Ependymoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ependymoma surgery On the Web |
|
American Roentgen Ray Society Images of Ependymoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Surgery is the main stay of treatment for myxopapillary ependymoma (WHO grade 1), subependymoma (WHO grade 1), ependymoma (WHO grade I), and anaplastic ependymoma (WHO grade III).
Surgery
- Anecdotal experience suggests that surgery alone for completely resected supratentorial nonanaplastic tumors and intradural spinal cord ependymomas may be an appropriate approach to treatment for:[1]
- Newly diagnosed myxopapillary ependymoma (WHO grade 1)
- Newly diagnosed subependymoma (WHO grade 1)
- Newly diagnosed ependymoma (WHO grade I)
- Newly diagnosed anaplastic ependymoma (WHO grade III)
- Complete surgical removal is often curative. Some subependymomas are considered incidental findings and observed without intervention.
- Extensive surgical resection for anaplastic ependymoma (WHO grade III) in an attempt to maximize tumor resection is related to improved survival rate of patients.[2][3]
References
- ↑ Ependymoma http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq/#cit/section_7.1 URL Accessed on 10 8 2015
- ↑ Tennyson VM, Mytilineou C, Heikkila R, Barrett RE, Cohen G, Côté L; et al. (1975). "Dopamine-containing neurons of the substantia nigra and their terminals in the neostriatum". UCLA Forum Med Sci (18): 227–64. PMID 827-35 Check
|pmid=value (help). - ↑ Zourlas PA (1975). "Response to exogenous gonadotropins in the unresponsive ovary syndrome". Int J Gynaecol Obstet. 13 (1): 23–8. PMID 258-66 Check
|pmid=value (help).